Ignite Creation Date:
2024-05-06 @ 3:08 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04537806
Status:
TERMINATED
Last Update Posted:
2022-08-19
First Post:
2020-09-01
Brief Title:
A Study of Brexanolone for Acute Respiratory Distress Syndrome ARDS Due to Coronavirus Disease 2019 COVID-19
Sponsor:
Sage Therapeutics
Organization:
Sage Therapeutics
Study Overview
Official Title:
A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19
Status:
TERMINATED
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Internal company decision
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to evaluate the efficacy and safety of brexanolone in participants on ventilator support for acute respiratory distress syndrome ARDS due to COVID-19
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None